Northwire Canada EditionThursday, July 16, 2026
Sign inSubscribe
Northwire
⌕
GGAU 0.190 +0.0% KIRO 0.640 +0.0% LBNK 0.430 +0.0% BARU 0.040 +0.0% VCU 1.10 −3.5% NOBL 0.100 +0.0% SHL 0.360 +1.4% MTS 0.130 +0.0% FYL 0.090 +0.0% NUAG 5.45 +0.0% CAM 0.330 −1.5% SYH 0.400 −1.2% LOT 0.040 +0.0% CPL 0.180 −5.3% OTMC 0.410 +2.5% PEX 0.180 −2.7% GGAU 0.190 +0.0% KIRO 0.640 +0.0% LBNK 0.430 +0.0% BARU 0.040 +0.0% VCU 1.10 −3.5% NOBL 0.100 +0.0% SHL 0.360 +1.4% MTS 0.130 +0.0% FYL 0.090 +0.0% NUAG 5.45 +0.0% CAM 0.330 −1.5% SYH 0.400 −1.2% LOT 0.040 +0.0% CPL 0.180 −5.3% OTMC 0.410 +2.5% PEX 0.180 −2.7%

Healthcare

Page 85
  1. Dec 16, 2025 · 08:16 · NLH

    Nova Leap Health Corp. Launches Care Management Division In the United States

    Nova Leap Health Corp. Launches Care Management Division In the United States

    01
  2. Dec 16, 2025 · 07:40 · ARCH

    Arch Biopartners Announces Ethics Approval for St. Michael's Hospital to Participate in the Phase II Cardiac Surgery-Associated AKI Trial for LSALT Peptide

    Arch Biopartners Announces Ethics Approval for St. Michael's Hospital to Participate in the Phase II Cardiac Surgery-Associated AKI Trial for LSALT Peptide

    02
  3. Dec 15, 2025 · 18:25 · AIAI

    Netramark completes FDA AI meeting

    Netramark completes FDA AI meeting

    03
  4. Dec 15, 2025 · 17:52 · QIPT

    Quipt signs deal for acquisition by Kingswood, Forager

    Quipt signs deal for acquisition by Kingswood, Forager

    04
  5. Dec 15, 2025 · 17:30 · HBP

    Helix BioPharma Corp. Announces Filing of Interim Financial Statements as of and for the Three-Month Period Ended October 31, 2025

    Helix BioPharma Corp. Announces Filing of Interim Financial Statements as of and for the Three-Month Period Ended October 31, 2025

    05
  6. Dec 15, 2025 · 17:09 · RVV

    Revive Therapeutics primes the pump on Bucillamine

    Revive Therapeutics primes the pump on Bucillamine

    06
  7. Dec 15, 2025 · 17:05 · PTEC

    PRINCIPAL TECHNOLOGIES CLOSES PRIVATE PLACEMENT FINANCING

    PRINCIPAL TECHNOLOGIES CLOSES PRIVATE PLACEMENT FINANCING

    07
  8. Dec 15, 2025 · 17:01 · VIVI

    TempraMed Strengthens Global Intellectual Property Position with Grant of South Korean Patent

    TempraMed Strengthens Global Intellectual Property Position with Grant of South Korean Patent

    08
  9. Dec 15, 2025 · 16:30 · RX

    BioSyent Announces Renewal of Normal Course Issuer Bid

    BioSyent Announces Renewal of Normal Course Issuer Bid

    09
  10. Dec 15, 2025 · 12:29 · MDX

    MedX Health reviews 2025

    MedX Health reviews 2025

    10
  11. Dec 15, 2025 · 08:30 · AIAI

    NetraMark Achieves Major FDA Milestone

    NetraMark Achieves Major FDA Milestone

    11
  12. Dec 15, 2025 · 07:30 · QIPT

    Quipt Home Medical Enters Into Definitive Agreement for Its Acquisition by Affiliates of Kingswood Capital Management and Forager Capital Management

    Quipt Home Medical Enters Into Definitive Agreement for Its Acquisition by Affiliates of Kingswood Capital Management and Forager Capital Management

    12
  13. Dec 15, 2025 · 07:30 · RVV

    Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study

    Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study

    13
  14. Dec 15, 2025 · 07:30 · QIPT

    Quipt Home Medical Reports Fourth Quarter and Fiscal Year 2025 Financial Results

    Quipt Home Medical Reports Fourth Quarter and Fiscal Year 2025 Financial Results

    14
← Newer Older →